Cargando…

Small Molecules Targeting Viral RNA

The majority of antivirals available target viral proteins; however, RNA is emerging as a new and promising antiviral target due to the presence of highly structured RNA in viral genomes fundamental for their replication cycle. Here, we discuss methods for the identification of RNA-targeting compoun...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathez, Gregory, Cagno, Valeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487773/
https://www.ncbi.nlm.nih.gov/pubmed/37686306
http://dx.doi.org/10.3390/ijms241713500
_version_ 1785103320496472064
author Mathez, Gregory
Cagno, Valeria
author_facet Mathez, Gregory
Cagno, Valeria
author_sort Mathez, Gregory
collection PubMed
description The majority of antivirals available target viral proteins; however, RNA is emerging as a new and promising antiviral target due to the presence of highly structured RNA in viral genomes fundamental for their replication cycle. Here, we discuss methods for the identification of RNA-targeting compounds, starting from the determination of RNA structures either from purified RNA or in living cells, followed by in silico screening on RNA and phenotypic assays to evaluate viral inhibition. Moreover, we review the small molecules known to target the programmed ribosomal frameshifting element of SARS-CoV-2, the internal ribosomal entry site of different viruses, and RNA elements of HIV.
format Online
Article
Text
id pubmed-10487773
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104877732023-09-09 Small Molecules Targeting Viral RNA Mathez, Gregory Cagno, Valeria Int J Mol Sci Review The majority of antivirals available target viral proteins; however, RNA is emerging as a new and promising antiviral target due to the presence of highly structured RNA in viral genomes fundamental for their replication cycle. Here, we discuss methods for the identification of RNA-targeting compounds, starting from the determination of RNA structures either from purified RNA or in living cells, followed by in silico screening on RNA and phenotypic assays to evaluate viral inhibition. Moreover, we review the small molecules known to target the programmed ribosomal frameshifting element of SARS-CoV-2, the internal ribosomal entry site of different viruses, and RNA elements of HIV. MDPI 2023-08-31 /pmc/articles/PMC10487773/ /pubmed/37686306 http://dx.doi.org/10.3390/ijms241713500 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mathez, Gregory
Cagno, Valeria
Small Molecules Targeting Viral RNA
title Small Molecules Targeting Viral RNA
title_full Small Molecules Targeting Viral RNA
title_fullStr Small Molecules Targeting Viral RNA
title_full_unstemmed Small Molecules Targeting Viral RNA
title_short Small Molecules Targeting Viral RNA
title_sort small molecules targeting viral rna
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487773/
https://www.ncbi.nlm.nih.gov/pubmed/37686306
http://dx.doi.org/10.3390/ijms241713500
work_keys_str_mv AT mathezgregory smallmoleculestargetingviralrna
AT cagnovaleria smallmoleculestargetingviralrna